Biogen proposes to buy remaining stake in Sage in $442 million deal
(Reuters) - Drugmaker Biogen will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 ...
Read moreDetailsTag: outstanding shares
Software Firm ServiceTitan Seeks Up to $502 Million in IPO
(Bloomberg) -- Home service software business ServiceTitan Inc. is seeking to raise as much as $501.6 million in an initial ...
Read moreDetails
